The Hindu Business Line

Share

The Hindu Business Line

 •  December 8

New Delhi, Dec 8: Glenmark Pharma today said the first patient has been dosed in a phase-1 clinical trial of GBR 1342, an investigational antibody for treatment of multiple myeloma. In May this year, the US health regulator had cleared Glenmark Pharma’s investigational new drug application to initiate phase-1 study of GBR 1342. GBR 1342 is an...

The Hindu Business Line

 •  November 10

Mumbai, November 8: It is just the tip of the iceberg, Connecticut Attorney General George Jepsen had said when a handful of drug-makers were hauled to Court last December for alleged involvement in price collusion in the US. Close to a year on, that cautionary statement has come true. Or as a recent announcement from his office explains, the...

The Hindu Business Line

 •  November 2

Lawsuit filed in December 2016 seeks to widen probe to Sun Pharma, Dr Reddy's Laboratories, Glenmark Generics Ltd, Alkem Laboratories, Zydus Pharma Washington, Nov 2: A large group of US states accused key players in the generic drug industry of a broad price-fixing conspiracy, moving on Tuesday to widen an earlier lawsuit to add many more...

The Hindu Business Line

 •  October 25

Hyderabad, October 25: Contract research and development company GVK Bio has a mobile application, eCule, for drug discovery services. The application brings the biology and chemistry services offered by the Hyderabad-based company under one roof. “It simplifies the whole ordering process from inquiry to delivery and also allows live tracking to...

New Delhi, May 17: The National Pharmaceutical Pricing Authority has pulled up 67 pharma companies — including Lupin, Glenmark, GSK Pharma, Cadila, Biocon and Abbott — for 201 medicines that tried to violate the price control by taking advantage of loopholes. Pharmaceutical companies appear to have found a way around the strict price control...

The Hindu Business Line

 •  February 26

Regulatory actions on some players are a ‘wake up call’ to bring in more discipline Mumbai, February 24: Initial skepticism has given way to healthy collaboration with some of the top drugmakers in the country coming together to up quality standards not just in their companies, but for the larger pharmaceutical industry. The vision on setting a...